Please use this identifier to cite or link to this item: 10.2478/v10046-011-0023-3
Title: Neopterins, šūnu adhēzijas molekulas un mieloperoksidāze pacientiem ar stabilu un nestabilu stenokardiju
Other Titles: Neopterin, cellular adhesion molecules and myeolperoxidase in patients with stable and unstable angina pectoris
Authors: Tretjakovs, Pteris
Jurka, Antra
Bormane, Inga
Miķelsone, Indra
Reihmane, Dace
Krieviņa, Gita
Marksa, Iveta
Elksne, Karlina
Verbovenko, Jurijs
Bahs, Guntis
Department of Human Physiology and Biochemistry
Keywords: angina pectoris;cellular adhesion molecules;coronary artery disease;metabolic syndrome;myeloperoxidase;neopterin;3.2 Clinical medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;General
Issue Date: 1-Jan-2011
Citation: Tretjakovs , P , Jurka , A , Bormane , I , Miķelsone , I , Reihmane , D , Krieviņa , G , Marksa , I , Elksne , K , Verbovenko , J & Bahs , G 2011 , ' Neopterins, šūnu adhēzijas molekulas un mieloperoksidāze pacientiem ar stabilu un nestabilu stenokardiju ' , Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences , vol. 65 , no. 3-4 , pp. 87-93 . https://doi.org/10.2478/v10046-011-0023-3
Abstract: Recent data indicate that the serum level of neopterin, a marker of inflammation and immune modulator secreted by monocytes/macrophages, is elevated in patients with acute coronary syndrome (ACS) and seems to be a prognostic marker for major cardiovascular events. Soluble cellular adhesion molecules (sCAMs) and myeloperoxidase (MPO) levels are also related to ACS. The aim of the present study was to evaluate differences in serum levels of neopterin, sCAMs and MPO between coronary artery disease and metabolic syndrome (CAD-MetS) patients with stable and unstable angina pectoris (SAP, UAP), and to clarify the relationships between neopterin and other biomarkers. The study included 60 patients with CAD-MetS who were classified into two groups, 30 patients with SAP and 30 patients with UAP. Twenty healthy subjects were selected as controls (C). Serum soluble vascular cell adhesion molecule-1 (sVCAM-1), intercellular cell adhesion molecule-1 (sICAM-1), sE-selectin and MPO levels were measured by Luminex xMAP technology, and serum neopterin concentrations were measured by radioimmunoassay. Results: Serum levels of neopterin, MPO, sVCAM-1, sICAM-1, and sE-selectin were significantly higher in patients with UAP in comparison with the group of healthy controls (P < 0.05). Patients with SAP also had higher levels of these biomarkers than those in healthy controls (P < 0.05), except for sE-selectin. The biomarker level did not differ between the two patient groups, except for MPO, which was significantly higher in the USP group (P < 0.05). Neopterin was significantly correlated only with sVCAM-1 (P < 0.05). In conclusion, CAD-Met patients with SAP had more apparent raised levels of serum sICAM-1 and sVCAM-1, simultaneously with higher MPO and neopterin concentrations, in comparison to those in healthy subjects. However, UAP is also associated with more substantial changes in MPO and significantly increased sE-selectin levels. Neopterin concentration was had a close correlation only with sVCAM-1.
DOI: 10.2478/v10046-011-0023-3
ISSN: 1407-009X
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.